This study analyzes 20 years of data from the Food and Drug Administration’s Adverse Event Reporting System (FAERS) to reveal ...
No increased risk for cancer was found among patients with RA receiving biologic or targeted synthetic DMARDs vs TNF inhibitors.
A six-year cohort study shows low muscle strength, not sarcopenia, is linked to increased falls risk in patients with ...
DISABLED ENTREPRENEUR UK on MSN
Understanding Autoimmune diseases now affects one in 10 people
The increasing prevalence of autoimmune diseases represents a significant global health challenge, necessitating concerted ...
The European regulator has recommended marketing approval for Ranluspec and Gotenfia after studies confirm their safety, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback